New chemo drug could mean fewer shots for kids with blood cancer
NCT ID NCT01574274
First seen Feb 05, 2026 · Last updated Apr 28, 2026 · Updated 12 times
Summary
This study compares a new form of chemotherapy (calaspargase pegol) given every 3 weeks to the standard form (Oncaspar) given every 2 weeks in children and teens with acute lymphoblastic leukemia or lymphoblastic lymphoma. The goal is to see if the new drug has similar side effects and drug levels, and if adjusting treatment based on early cancer cell levels can improve cure rates. The study also tests giving antibiotics early to prevent serious infections and looks at vitamin D levels to reduce bone problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier U. de Quebec
Québec, Quebec, Canada
-
Children's Hospital Boston
Boston, Massachusetts, 02215, United States
-
Columbia University Medical Center, Morgan Stanley Children's Hospital of New York-Presbyterian
New York, New York, 10032, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Hasbro Children's Hospital
Providence, Rhode Island, 02903, United States
-
Hospital Sainte Justine, University of Montreal
Montreal, Quebec, Canada
-
McMaster University
Hamilton, Ontario, Canada
-
Montefiore Medical Center
New York, New York, 10467, United States
Conditions
Explore the condition pages connected to this study.